Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rude Awakening Could Await China (China)

This article was originally published in PharmAsia News

Executive Summary

China's lack of oversight concerning its pharmaceutical and food industries may lead to a global backlash against China as countries shy away from or even ban importation of Chinese medicines and food products. The United States on May 24 requested that China increase its oversight on food and drug export products. America and China currently are engaged in wide-ranging trade talks in which the United States is focusing on demanding China's currency be permitted to fluctuate more. The U.S. Food and Drug administration already has banned all U.S. imports of China-made toothpaste, after some Chinese toothpaste was found to contain an ingredient used in automotive antifreeze. Further problems in sensitive industries such as pharmaceuticals and food products may lead to trade embargo legislation against China from the U.S. Congress. Such incidents also would reverberate around the world, wounding China's food and pharmaceutical export companies. (Click here for more - May Require Free Registration

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel